Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs

导出原文传递

翻译打印收藏纠错

作者： Patwardhan,P.P. ^[1] ; Surriga,O. ^[2] ; Beckman,M.J. ^[3] ; DeStanchina,E. ^[4] ; Dematteo,R.P. ; Tap,W.D. ; Schwartz,G.K.

作者单位： Jennifer Goodman Linn Laboratory of New Drug Development, Department of Medicine, Columbia ^[1] Department of Surgery, Memorial Sloan Kettering Cancer Center, Columbia University Medical Center ^[2] Department of Molecular Pharmacology and Chemistry, Columbia University Medical Center, New York ^[3] Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, United States ^[4]

发布时间 2014-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical cancer research

2014年20卷12期

3146-3158页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sustained inhibition of receptor tyrosine kinases and macrophage depletion by PLX3397 and rapamycin as a potential new approach for the treatment of MPNSTs

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除